GEORGE WASHINGTON UNIVERSITY

Latigo Biotherapeutics appoints Tim Lugo as CFO and Beth Seidenberg, M.D., and Jim Tananbaum, M.D., to its board to advance non-opioid pain medicine development.

Join The Kensington Falls Church and Neurologist Jennifer Pauldurai, MD of Inova for an event on Alzheimer’s treatment, including the FDA-approved Donanemab. The session will also cover managing behavioral symptoms like stress, agitation, and mood changes, providing practical strategies for caregivers and loved ones.

CCR West celebrates its 40th anniversary with a focus on CAR T-cell therapy and precision medicine, featuring cutting-edge research and presentations by leading experts in rheumatology.

Bruce Feinberg, DO, Chief Medical Officer at Cardinal Health, is recognized for expertise in oncology and specialty healthcare, developing clinical pathways to control costs and improve quality. Scott Swain, PhD, MPH, Senior Director of Regulatory and Real-World Evidence, focuses on improving regulatory submissions using real-world evidence. Tammy Schuler, PhD, Senior Scientist at Cardinal Health, specializes in patient-reported outcomes and electronic medical records research, with a focus on cancer health outcomes.

Elinzanetant, a dual NK-1 and 3 receptor antagonist, showed efficacy and safety in Phase III OASIS 1 and 2 studies for treating moderate to severe VMS in menopause, reducing VMS frequency and severity, and improving sleep disturbances and quality of life.